Malta-based Fimbank and pharmaceutical giant Actavis are collaborating to send an “urgent” shipment of medicines to Libya to be distributed in private and public hospitals impacted by the ongoing conflict.

Actavis, which operates a manufacturing plant in Malta, has agreed to provide part of the required supplies free of charge, while Fimbank will be waiving all fees and interest charges for international trade services connected with this shipment.

The initiative, in which other pharmaceutical companies operating in Malta have also shown an interest, has received the approval and help of the government and other agencies to avoid the bureaucratic process.

The shipment is expected to arrive in Libya within the next few days, where it will be received by the Libyan health authorities for distribution to public and private hospitals.

Independent journalism costs money. Support Times of Malta for the price of a coffee.

Support Us